Manipal Health Enterprises Limited (MANIPALHOS) — Announcement | 20 August 2026(2 announcements)

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Announcement Neutral 📄 PDF
📢 Key Event
Manipal Health reports Q1 FY27 results with 38.1% revenue growth
🔄 What Changed
38.1% YoY revenue growth, 26.4% YoY EBITDA growth, 38.8% inpatient volume increase
🔮 What's Next
Integration of Sahyadri Hospitals to unlock further benefits through clinical integration and operating scale
💡 Investor Takeaway
The company delivered strong growth post-listing with operational momentum continuing across its expanded network.

Manipal Health Enterprises Limited reported Q1 FY27 results showing 38.1% YoY revenue growth to ₹3,091 crore and 26.4% YoY EBITDA growth to ₹749 crore, driven by strong patient volume increases and Sahyadri integration. The company highlighted 38.8% inpatient volume growth and 65% occupancy, with adjusted PAT reaching ₹243 crore after excluding ₹89 crore of post-tax interest on acquisition debt. The filing marks the company's first results since its August 5, 2026 listing, demonstrating successful network expansion and operational efficiency gains across its pan-India hospital chain.

2 Announcement Neutral 📄 PDF
📢 Key Event
Manipal Health Enterprises reports Q1 FY27 results post-listing
🔄 What Changed
38.1% YoY revenue growth, 26.4% YoY EBITDA growth, 38.8% inpatient volume increase
🔮 What's Next
Integration of Sahyadri Hospitals to unlock further benefits through clinical integration and operating scale
💡 Investor Takeaway
The company delivered strong growth post-listing with operational momentum continuing in high-acuity specialties.

Manipal Health Enterprises Limited reported Q1 FY27 results showing 38.1% YoY revenue growth to ₹3,091 crore and 26.4% YoY EBITDA growth to ₹749 crore, driven by strong patient volume increases and Sahyadri integration. The company highlighted 38.8% inpatient volume growth and 65% occupancy, with adjusted PAT reaching ₹243 crore after excluding ₹89 crore of post-tax interest on acquisition-related NCDs. The filing marks the first earnings release following the company's August 5, 2026 listing, demonstrating successful network expansion and operational efficiency gains across its pan-India hospital network.

About Manipal Health Enterprises Limited (MANIPALHOS)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹98,258.68 Cr

View full MANIPALHOS stock details →

📡 Get AI alerts when MANIPALHOS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANIPALHOS — Free

📊 More MANIPALHOS filings

See all MANIPALHOS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MANIPALHOS files new disclosures

Track MANIPALHOS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANIPALHOS — Free

Free account · 2 AI queries/day